A team of researchers sought to describe efficacy and safety analyses of the Global Open-Label Extension (OLE) study of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy.
The objective of this study was to evaluate whether a retinal SD-OCT assessment at baseline is associated with long-term disability worsening in people with MS over 10 years.
As January is National Glaucoma Awareness Month, promoting awareness of the various dietary methods for reducing glaucoma risk will help patients maintain their visual health.
